Glucose intolerance after chronic stress is related with downregulated PPAR-γ in adipose tissue

Cardiovascular Diabetology

Volumn 15, Issue 1, 2016, Pages

  Pereira, Vitor H ^a,b   Marques, Fernanda ^a,b   Lages, Vânia ^a,b   Pereira, Filipa G ^a,b   Patchev, Alexandre ^c   Almeida, Osborne F X ^c   Almeida Palha, Joana ^a,b   Sousa, Nuno ^a,b   Cerqueira, João J ^a,b  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF MINHO   (Portugal)

^c MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Chronic unpredictable stress; Glucose intolerance; Lipocalin 2; Metabolic syndrome; PPAR; White adipose tissue

Indexed keywords

CORTICOSTEROID; CXCL1 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1; LIPOPROTEIN LIPASE; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; BIOLOGICAL MARKER; CORTICOSTERONE; GLUCOSE BLOOD LEVEL; INSULIN; LCN2 PROTEIN, RAT; PPAR GAMMA, RAT;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CELL INFILTRATION; CHRONIC STRESS; CONTROLLED STUDY; CORTICOSTEROID BLOOD LEVEL; DISEASE PREDISPOSITION; DOWN REGULATION; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MACROPHAGE; MALE; MONOCYTE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WEIGHT GAIN; WHITE ADIPOSE TISSUE; YOUNG ADULT; ANIMAL; BLOOD; CHRONIC DISEASE; COMPLICATION; DISEASE MODEL; GENETICS; GLUCOSE BLOOD LEVEL; INTRAABDOMINAL FAT; MENTAL STRESS; METABOLISM; PATHOPHYSIOLOGY; PHENOTYPE; TIME FACTOR; WISTAR RAT;

ANIMALS; BIOMARKERS; BLOOD GLUCOSE; CHRONIC DISEASE; CORTICOSTERONE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GLUCOSE INTOLERANCE; INFLAMMATION MEDIATORS; INSULIN; INTRA-ABDOMINAL FAT; LIPOCALIN-2; MALE; PHENOTYPE; PPAR GAMMA; RATS, WISTAR; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL; TIME FACTORS; WEIGHT GAIN;

EID: 84982216636     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/s12933-016-0433-2     Document Type: Article

References (48)

1. Kyrou I, Tsigos C. Stress hormones: physiological stress and regulation of metabolism. Curr Opin Pharmacol. 2009;9:787-93.
2. Chandola T, Brunner E, Marmot M. Chronic stress at work and the metabolic syndrome: prospective study. BMJ. 2006;332:521-5.
3. Björntorp P, Rosmond R. Hypothalamic origin of the metabolic syndrome X. Ann NY Acad Sci. 1999;892:297-307.
4. Karatsoreos IN, Bhagat SM, Bowles NP, Weil ZM, Pfaff DW, McEwen BS. Endocrine and physiological changes in response to chronic corticosterone: a potential model of the metabolic syndrome in mouse. Endocrinology. 2010;151:2117-27.
5. Bergmann N, Gyntelberg F, Faber J. The appraisal of chronic stress and the development of the metabolic syndrome: a systematic review of prospective cohort studies. Endocr Connect. 2014;3:R55-80.
6. Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab. 2009;94:2692-701.
7. Cornier M-A, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, et al. The metabolic syndrome. Endocr Rev. 2008;29:777-822.
8. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860-7.
9. Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 2004;25:4-7.
10. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115:1111-9.
11. Kuo LE, Czarnecka M, Kitlinska JB, Tilan JU, Kvetnanský R, Zukowska Z. Chronic stress, combined with a high-fat/high-sugar diet, shifts sympathetic signaling toward neuropeptide Y and leads to obesity and the metabolic syndrome. Ann NY Acad Sci. 2008;1148:232-7.
12. Abe K, Kuo L, Zukowska Z. Neuropeptide Y is a mediator of chronic vascular and metabolic maladaptations to stress and hypernutrition. Exp Biol Med. 2010;235:1179-84.
13. Yan Q-W, Yang Q, Mody N, Graham TE, Hsu C-H, Xu Z, et al. The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes. 2007;56:2533-40.
14. Ippoliti F, Canitano N, Businaro R. Stress and obesity as risk factors in cardiovascular diseases: a neuroimmune perspective. J Neuroimmune Pharmacol. 2013;8:212-26.
15. Bremer AA, Jialal I. Adipose tissue dysfunction in nascent metabolic syndrome. J Obes. 2013;2013:393192.
16. Ahmadian M, Suh JM, Hah N, Liddle C, Atkins AR, Downes M, et al. PPARγ signaling and metabolism: the good, the bad and the future. Nat Med. 2013;19:557-66.
17. Ferré P. The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity. Diabetes. 2004;53:S43-50.
18. Wang Y-X. PPARs: diverse regulators in energy metabolism and metabolic diseases. Cell Res. 2010;20:124-37.
19. Marques F, Mesquita SD, Sousa JC, Coppola G, Gao F, Geschwind DH, et al. Lipocalin 2 is present in the EAE brain and is modulated by natalizumab. Front Cell Neurosci. 2012;6:33.
20. Fonseca C, Taatjes DJ, Callas P, Ittleman F, Bovill EG. The effects of aging on the intimal region of the human saphenous vein: insights from multimodal microscopy and quantitative image analysis. Histochem Cell Biol. 2012;138:435-45.
21. Tamashiro KLK, Nguyen MMN, Fujikawa T, Xu T, Yun Ma L, Woods SC, et al. Metabolic and endocrine consequences of social stress in a visible burrow system. Physiol Behav. 2004;80:683-93.
22. Zardooz H, Zahedi Asi S, Gharib Naseri MK, Hedayati M. Effect of chronic restraint stress on carbohydrate metabolism in rat. Physiol Behav. 2006;89:373-8.
23. Kuo LE, Kitlinska JB, Tilan JU, Li L, Baker SB, Johnson MD, et al. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med. 2007;13:803-11.
24. García-Díaz DF, Campion J, Milagro FI, Lomba A, Marzo F, Martínez JA. Chronic mild stress induces variations in locomotive behavior and metabolic rates in high fat fed rats. J Physiol Biochem. 2007;63:337-46.
25. Depke M, Fusch G, Domanska G, Geffers R, Völker U, Schuett C, et al. Hypermetabolic syndrome as a consequence of repeated psychological stress in mice. Endocrinology. 2008;149:2714-23.
26. Fu J, Xie S, Kong S, Wang Y, Wei W, Shan Y, et al. The combination of a high-fat diet and chronic stress aggravates insulin resistance in Wistar male rats. Exp Clin Endocrinol Diab. 2009;117:354-60.
27. Uchida Y, Takeshita K, Yamamoto K, Kikuchi R, Nakayama T, Nomura M, et al. Stress augments insulin resistance and prothrombotic state: role of visceral adipose-derived monocyte chemoattractant protein-1. Diabetes. 2012;61:1552-61.
28. Fernando HA, Chin H-F, Ton SH, Kadir KA. Stress and its effects on glucose metabolism and 11β-HSD activities in rats fed on a combination of high-fat and high-sucrose diet with glycyrrhizic acid. J Diab Res. 2013;2013:190395.
29. Karagiannides I, Golovatscka V, Bakirtzi K, Sideri A, Salas M, Stavrakis D, et al. Chronic unpredictable stress regulates visceral adipocyte-mediated glucose metabolism and inflammatory circuits in male rats. Physiol Rep. 2014;2:e00284.
30. Zlatković J, Todorović N, Bošković M, Pajović SB, Demajo M, Filipović D. Different susceptibility of prefrontal cortex and hippocampus to oxidative stress following chronic social isolation stress. Mol Cell Biochem. 2014;393(1-2):43-57.
31. Macedo IC, Medeiros LF, Oliveira C, Oliveira CM, Rozisky JR, Scarabelot VL, et al. Cafeteria diet-induced obesity plus chronic stress alter serum leptin levels. Peptides. 2012;38:189-96.
32. Paternain L, de la Garza AL, Batlle MA, Milagro FI, Martínez JA, Campión J. Prenatal stress increases the obesogenic effects of a high-fat-sucrose diet in adult rats in a sex-specific manner. Stress. 2013;16:220-32.
33. Matsusue K, Haluzik M, Lambert G, Yim S-H, Gavrilova O, Ward JM, et al. Liver-specific disruption of PPARγ in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. J Clin Invest. 2003;111:737-47.
34. He J, Quintana MT, Sullivan J, Parry L, Grevengoed TJ, Schisler JC, et al. MuRF2 regulates PPARγ1 activity to protect against diabetic cardiomyopathy and enhance weight gain induced by a high fat diet. Cardiovasc Diabetol. 2015;14:97.
35. Vidal-Puig AJ, Considine RV, Jimenez-Liñan M, Werman A, Pories WJ, Caro JF, et al. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest. 1997;99:2416-22.
36. Yumuk VD. Targeting components of the stress system as potential therapies for the metabolic syndrome: the peroxisome-proliferator-activated receptors. Ann NY Acad Sci. 2006;1083:306-18.
37. Sharma AM, Staels B. Peroxisome proliferator-activated receptor gamma and adipose tissue-understanding obesity-related changes in regulation of lipid and glucose metabolism. J Clin Endocrinol Metab. 2007;92:386-95.
38. Glass CK, Olefsky JM. Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab. 2012;15:635-45.
39. Anghel SI, Wahli W. Fat poetry: a kingdom for PPARγ. Cell Res. 2007;17:486-511.
40. López-López AL, Jaime HB, Villanueva MDCE, Padilla MB, Palacios GV, Aguilar FJA. Chronic unpredictable mild stress generates oxidative stress and systemic inflammation in rats. Physiol Behav. 2016;161:15-23.
41. Jin D, Guo H, Bu SY, Zhang Y, Hannaford J, Mashek DG, et al. Lipocalin 2 is a selective modulator of peroxisome proliferator-activated receptor-gamma activation and function in lipid homeostasis and energy expenditure. FASEB J. 2011;25:754-64.
42. Ni J, Ma X, Zhou M, Pan X, Tang J, Hao Y, et al. Serum lipocalin-2 levels positively correlate with coronary artery disease and metabolic syndrome. Cardiovasc Diabetol. 2013;12:176.
43. Zhang J, Wu Y, Zhang Y, Leroith D, Bernlohr DA, Chen X. The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages. Mol Endocrinol. 2008;22:1416-26.
44. Law IKM, Xu A, Lam KSL, Berger T, Mak TW, Vanhoutte PM, et al. Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity. Diabetes. 2010;59:872-82.
45. Guo H, Jin D, Zhang Y, Wright W, Bazuine M, Brockman DA, et al. Lipocalin-2 deficiency impairs thermogenesis and potentiates diet-induced insulin resistance in mice. Diabetes. 2010;59:1376-85.
46. Zhao P, Elks CM, Stephens JM. The induction of lipocalin-2 protein expression in vivo and in vitro. J Biol Chem. 2014;289:5960-9.
47. d'Audiffret AC, Frisbee SJ, Stapleton PA, Goodwill AG, Isingrini E, Frisbee JC. Depressive behavior and vascular dysfunction: a link between clinical depression and vascular disease? J Appl Physiol. 2010;108:1041-51.
48. House LM, Morris RT, Barnes TM, Lantier L, Cyphert TJ, McGuinness OP, et al. Tissue inflammation and nitric oxide-mediated alterations in cardiovascular function are major determinants of endotoxin-induced insulin resistance. Cardiovasc Diabetol. 2015;14:56.